Our Active Investigational New Drug & In Vitro Diagnostic Pipeline
We are developing breakthrough solutions to transform patient outcomes - DNA methylation tests to detect cancer earlier and limbal stem cell exosome therapies to restore ocular hydration and reduce inflammation - both moving through robust research and clinical pipelines.
3D Global Biotech - Limbal Stem Cell Exosome Therapeutics Pipeline
EG BioMed - DNA Methylation Cancer Screening Tests Pipeline
Our Active Services & Product Pipeline
We currently provide commercially available laboratory-developed cancer detection tests through our CAP-accredited, CLIA-certified laboratory, along with established eye care products including artificial tears and contact lenses, while continuing to advance additional detection tests through our development pipeline.
Eye Care Portfolio
Laboratory-Developed Test (LDT) Portfolio